AI assistant
PFIZER INC — Director's Dealing 2019
Feb 6, 2019
29831_dirs_2019-02-06_4019169e-00f8-4491-84f1-ffa8bc211cbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-04
Reporting Person: DAMELIO FRANK A (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-04 | Common Stock | I | 5182.0000 | $42.4400 | Disposed | 0.0000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-04 | Phantom Stock Units SSP | $ | I | 42690.0000 | Disposed | Common Stock (42690.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 337391.0000 | Direct |
Footnotes
F1: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.
F2: Each unit represents one phantom share of common stock.
F3: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
F4: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.